NVAX logo

NVAX
Novavax Inc

107,599
Mkt Cap
$1.31B
Volume
4.44M
52W High
$11.97
52W Low
$5.80
PE Ratio
3.40
NVAX Fundamentals
Price
$8.93
Prev Close
$8.10
Open
$8.61
50D MA
$9.04
Beta
1.41
Avg. Volume
3M
EPS (Annual)
$2.54
P/B
-10.31
Rev/Employee
$1.5M
$695.34
Loading...
Loading...
News
all
press releases
Novavax Q1 2026 Earnings Call Transcript
read more...
Benzinga·58m ago
News Placeholder
More News
News Placeholder
Novavax Tops Expectations On High-Margin Deals – Retail Says ‘It’s The Only Thing That Matters’
Total revenue for the first quarter fell to $140 million, but came above analysts’ estimates of roughly $81 million, according to Fiscal.ai data.
Stocktwits·1h ago
News Placeholder
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?
ANI Pharmaceuticals, Novavax and three other biotechs show strong Earnings ESP signals, hinting at potential Q1 earnings beat as sector results roll in.
Zacks·2d ago
News Placeholder
Novavax (NVAX) to Release Earnings on Wednesday
Novavax (NASDAQ:NVAX) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-novavax-inc-stock...
MarketBeat·4d ago
News Placeholder
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close.
Zacks·5d ago
News Placeholder
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Zacks·5d ago
News Placeholder
Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·6d ago
News Placeholder
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 PR Newswire GAITHERSBURG, Md., April 29, 2026 GAITHERSBURG...
PR Newswire·7d ago
News Placeholder
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks·9d ago
News Placeholder
Novavax (NVAX) Dips More Than Broader Market: What You Should Know
In the closing of the recent trading day, Novavax (NVAX) stood at $8.15, denoting a -3.55% move from the preceding trading day.
Zacks·13d ago
<
1
2
...
>

Latest NVAX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.